A dose- and schedule-finding study of darbepoetin alpha for the treatment of chronic anaemia of cancer

A multicentre study evaluated the efficacy and safety of darbepoetin alpha administered weekly (QW), every 3 weeks (Q3W), and every 4 weeks (Q4W) to anaemic patients with cancer not concurrently receiving chemotherapy or radiotherapy. The QW portion (n=102) was an open-label, sequential, dose-escala...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, R E, Tchekmedyian, N S, Chan, D, Meza, L A, Northfelt, D W, Patel, R, Austin, M, Colowick, A B, Rossi, G, Glaspy, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2741110/
https://www.ncbi.nlm.nih.gov/pubmed/12799626
http://dx.doi.org/10.1038/sj.bjc.6600994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2741110/
https://www.ncbi.nlm.nih.gov/pubmed/12799626
http://dx.doi.org/10.1038/sj.bjc.6600994

Ejemplares similares